Extrapolation of Oligonucleotide Dose Levels Used in Nonclinical Toxicity Studies to Selection of Safe Starting Dose Levels in Human Clinical Trials
Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2019.0781
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Mary Ann Liebert Inc